The 24th CPHI China 2026 (Worldwide Pharmaceutical Ingredients China) alongside the 19th PMEC China 2026 (Pharmaceutical Machinery, Packaging Equipment & Materials China), co-hosted by Informa Markets, China Chamber of Commerce for Import and Export of Light Industrial Products and Arts-Crafts, and Shanghai UBM Sinoexpo International Exhibition Co., Ltd., was held at Shanghai New International Expo Centre. The exhibition builds a full industrial chain ecosystem. Through cutting-edge technology showcases, in-depth industry exchanges and efficient resource matchmaking, it delivers substantial commercial value and strategic opportunities for enterprises, continuously fueling new momentum for the advancement of the pharmaceutical sector.

Innovative Raw Materials Driving Industrial Advancement

At this exhibition, Topscience Biotech showcased its star product portfolio, including Cross-linked Sodium Hyaluronate, PDRN & PN, Medical Device Grade Sodium Acetylated Hyaluronate, Medical Device Grade Chondroitin Sulfate Sodium, and a full range of Sodium Hyaluronate for pharmaceutical and cosmetic applications. Supported by a complete matrix of Pharmaceutical grade innovative raw materials, the company fully demonstrated its robust R&D capabilities and compliant manufacturing strengths.

(1) Cross-linked Sodium Hyaluronate: Leveraging mature, controllable crosslinking technology, the hardness and supporting force of cross-linked gel can be precisely regulated to deliver consistent and outstanding shaping performance. Critical indicators such as endotoxin and crosslinker residues are strictly controlled throughout production, ensuring stable, uniform batch quality that fully complies with stringent medical device registration standards. Widely applicable to the development of Class II and III medical devices for wound repair, aesthetic fillers, ophthalmic preparations, orthopedic joint repair and other scenarios.

(2) PDRN & PN: Sourced from pure salmon testes with fully traceable raw materials, complete natural molecular structures and ultra-high purity. The product covers a wide molecular weight range, with custom molecular weight services available to satisfy diverse end-formulation requirements. It features outstanding physicochemical stability; a gel system can be formed after sterilization at low concentrations, and its aqueous solution boasts superior transparency. This raw material is widely applied in Class II and III medical devices such as skin booster injections and dermal fillers.

(3) Medical Device Grade Sodium Acetylated Hyaluronate: Manufactured based on an independent patented modification process (Patent No.: ZL202510290861.6). Using high-purity sodium hyaluronate as the substrate, the acetyl group content is precisely controlled with rigorous endotoxin management. Its quality meets the standards of European Pharmacopoeia and the highest domestic quality control specifications for medical devices, featuring excellent biocompatibility and wide application coverage for all types of Class II and III medical devices.

(4) Medical Device Grade Chondroitin Sulfate Sodium: Made from shark cartilage raw materials via self-developed proprietary enzymatic hydrolysis technology that efficiently removes heteroproteins and trace impurities while preserving complete natural biological activity. Featuring high purity, low endotoxin levels and superior impurity indicators, it fills the market gap of domestically produced medical device grade chondroitin sulfate raw materials. Extensively applied to Class II and III medical devices for joint repair and knee protection therapies.

Technical Sharing to Jointly Explore New Industrial Horizons

On-site at the exhibition, Topscience Biotech delivered a keynote speech titled Innovation, Compliance & Services for Aesthetic-Medicinal Future. Centered on multiple innovative medical raw materials, the speech elaborated on upgraded process strengths and end-product application cases, systematically presenting the company’s core competitiveness covering self-developed manufacturing processes, complete compliance certifications, safety assurance systems and customized technical services. The team also engaged in thorough technical dialogues with industry peers in attendance.

Professional Team Delivers Comprehensive, Precise Empowerment

Topscience Biotech’s booth drew extensive attention from global merchants, pharmaceutical formulation manufacturers and R&D institutions throughout the show. Faced with a steady stream of visitors, the full sales team remained on duty, providing detailed briefings on product properties, compliance credentials, production capacity advantages and customized formulation solutions for the complete raw material lineup. By flexibly catering to R&D and mass production demands of diverse enterprises, the team built an efficient win-win cooperation platform via professional expertise and sincere service.

Successful Conclusion for Mutually Beneficial Growth

The successful wrap-up of CPHI China 2026 marks another solid milestone in Topscience Biotech’s global expansion journey. From extensive visitor engagement at the booth to in-depth technical exchanges during sharing sessions, Topscience Biotech demonstrated its professional standing as a pioneer of Sterile Sodium Hyaluronate manufacturers in China, backed by solid R&D achievements and a comprehensive compliance management system. Moving forward, Topscience Biotech will continue to focus on R&D and innovation in high-end pharmaceutical raw materials, including Sterile Sodium Hyaluronate, Cross-linked Sodium Hyaluronate, Medical Device Grade PDRN & PN, and Medical Device Grade Chondroitin Sulfate Sodium. The company will continuously expand global compliance certifications, optimize customized technical services, and empower the full industrial chains of global medical aesthetics, orthopedics and pharmaceuticals through high-quality raw material supply.

We look forward to joining hands with partners worldwide to build a new, secure, compliant and high-quality industrial future together!